Education
About Us
Working with TipRanks
Follow Us
Scandinavian ChemoTech AB Class B (DE:8V6)
:8V6
8V6 Stock Chart & Stats
€0.39
>-€0.01(-6.14%)
At close: 4:00 PM EST
€0.39
>-€0.01(-6.14%)
Day’s Range― - ―
52-Week Range€0.04 - €0.68
Previous CloseN/A
Volume0.00
Average Volume (3M)7.00
Market Cap
€9.95M
Enterprise Value€161.92M
Total Cash (Recent Filing)€517.00K
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta0.11
Next Earnings
Mar 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding21,692,312
10 Day Avg. Volume0
30 Day Avg. Volume7
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)6.99
Price to Sales (P/S)6.36
P/FCF Ratio-3.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Scandinavian ChemoTech AB Class B News
8V6 FAQ
What was Scandinavian ChemoTech AB Class B’s price range in the past 12 months?
Scandinavian ChemoTech AB Class B lowest stock price was €0.04 and its highest was €0.68 in the past 12 months.
What is Scandinavian ChemoTech AB Class B’s market cap?
Scandinavian ChemoTech AB Class B’s market cap is €9.95M.
When is Scandinavian ChemoTech AB Class B’s upcoming earnings report date?
Scandinavian ChemoTech AB Class B’s upcoming earnings report date is Mar 03, 2026 which is in 70 days.
How were Scandinavian ChemoTech AB Class B’s earnings last quarter?
Scandinavian ChemoTech AB Class B released its earnings results on Nov 04, 2025. The company reported -€0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.005.
Is Scandinavian ChemoTech AB Class B overvalued?
According to Wall Street analysts Scandinavian ChemoTech AB Class B’s price is currently Overvalued.
Does Scandinavian ChemoTech AB Class B pay dividends?
Scandinavian ChemoTech AB Class B does not currently pay dividends.
What is Scandinavian ChemoTech AB Class B’s EPS estimate?
Scandinavian ChemoTech AB Class B’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scandinavian ChemoTech AB Class B have?
Scandinavian ChemoTech AB Class B has 21,692,312 shares outstanding.
What happened to Scandinavian ChemoTech AB Class B’s price movement after its last earnings report?
Scandinavian ChemoTech AB Class B reported an EPS of -€0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.762%.
Which hedge fund is a major shareholder of Scandinavian ChemoTech AB Class B?
Currently, no hedge funds are holding shares in DE:8V6
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Scandinavian ChemoTech AB Class B
Scandinavian ChemoTech AB (publ) provides cancer care and pain management solutions. Its product, IQWave, is an electroporation device, which combines short electric pulses with chemotherapy administrated locally or intravenously used for treating head and neck squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. The company markets its products through distribution channels and a network of opinion leaders in South East Asia, India, and the Philippines. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.
Technical Analysis
2cureX AB
―
OncoZenge AB
―
ExpreS2ion Biotech Holding AB
―
CombiGene AB
―
Sprint Bioscience AB
―